February 03, 2017
Another Derma Sciences Inc. shareholder on Friday added his name to the list of proposed class actions filed against the company over Integra LifeSciences Holdings Corp.'s $204 million proposal to buy Derma, claiming that Derma's board of directors hid important information from investors.